Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials-Reference-Cited by-同舟云学术

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

Published:2020-05-22 Issue:5 Volume:17 Page:e1003117
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Moodie Zoe^ORCID,Walsh Stephen R.^ORCID,Laher Fatima^ORCID,Maganga Lucas^ORCID,Herce Michael E.^ORCID,Naidoo Sarita,Hosseinipour Mina C.^ORCID,Innes Craig^ORCID,Bekker Linda-Gail,Grunenberg Nicole^ORCID,Mann Philipp,Yu Chenchen,deCamp Allan C.^ORCID,Miner Maurine D.^ORCID,Yates Nicole L.,Heptinstall Jack^ORCID,Mkhize Nonhlanhla N.^ORCID,Dintwe One^ORCID,Frahm Nicole^ORCID,Cohen Kristen W.^ORCID,Allen Mary^ORCID,Hutter Julia^ORCID,Wagner Ralf,Pantaleo Giuseppe^ORCID,McElrath M. Juliana^ORCID,Tomaras Georgia D.^ORCID,Morris Lynn^ORCID,Montefiori David C.^ORCID,Andersen-Nissen Erica,Gray Glenda E.^ORCID,Gilbert Peter B.^ORCID,Kublin James G.,

Funder

National Institute of Allergy and Infectious Diseases

Bill and Melinda Gates Foundation

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference49 articles.

1. Lessons learned from HIV vaccine clinical efficacy trials;TA Day;Curr HIV Res,2013

2. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;S Rerks-Ngarm;N Engl J Med,2009

3. Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144;ML Robb;Lancet Infect Dis,2012

4. Immune-correlates analysis of an HIV-1 vaccine efficacy trial;BF Haynes;N Engl J Med,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a DNA vaccine with subtype C gp120 protein adjuvanted with MF59® or AS01B: a phase 1/2a HIV-1 vaccine trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-05-03

2. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial;PLOS Medicine;2024-03-19

3. Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention;Vaccines;2024-03-12

4. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects;Viruses;2024-02-27

5. The Regulation of Nucleic Acid Vaccine Responses by the Microbiome;The Journal of Immunology;2023-10-18